Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06887452 · ClinicalTrials.gov registry record · NA
Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout
A NA study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- NA
- Development phase
- 310
- Enrollment target
NCT06887452: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT06887452 is a NA study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 310 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06887452, a NA study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
Study Summary
This study will compare two different approaches to manage medications that lower uric acid levels. This study will be conducted at five VA medical centers across the United States and will take 4-5 years to complete. Individual participation will last up to two years.
Interventions
- OTHER Pharmacist-Led
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2026-10-01 |
| Est. Completion | 2031-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06887452
The ClinicalTrials.gov registry entry for NCT06887452 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 310 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pharmacist-Led is the first listed.
NCT06887452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06887452 about?
NCT06887452 is a clinical study titled "Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout". This study will compare two different approaches to manage medications that lower uric acid levels. This study will be conducted at five VA medical centers across the United States and will take 4-5 years to complete. Individual participation will last up to two years.
What is the current status of trial NCT06887452?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 310 participants. The study started on 2026-10-01. Estimated completion is 2031-03-30.
What interventions are being tested in trial NCT06887452?
The interventions under investigation include: Pharmacist-Led (OTHER).
Who is sponsoring clinical trial NCT06887452?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.